Search

Ulrich Tillmann Phones & Addresses

  • Frederick, MD
  • Charlotte, NC
  • 9808 Caitlins Ct, Ellicott City, MD 21042 (410) 465-7776 (410) 750-8748
  • Knoxville, MD
  • Reston, VA
  • Mc Henry, MD
  • Gaithersburg, MD
  • Wake Forest, NC
  • Mc Lean, VA
  • Mount Laurel, NJ

Publications

Us Patents

Moraxella Catarrhalis Protein, Nucleic Acid Sequence And Uses Thereof

View page
US Patent:
20090053292, Feb 26, 2009
Filed:
Dec 21, 2007
Appl. No.:
12/004502
Inventors:
Kenneth Tucker - Frederick MD, US
Ulrich F. Tillmann - Mount Laurel NJ, US
International Classification:
A61K 9/127
C07K 14/195
C12N 1/20
G01N 33/543
C12Q 1/68
C07K 16/12
A61K 39/02
US Classification:
424450, 530350, 530324, 4241901, 4352521, 5303895, 435 732, 435 6
Abstract:
The invention discloses the outer membrane protein polypeptide and polypeptides derived therefrom (collectively “OMP21”), nucleotide sequences encoding said OMP21, and antibodies that specifically bind OMP21. Also disclosed are pharmaceutical compositions including prophylactic or therapeutic compositions, which may be immunogenic compositions including vaccines, comprising OMP21, antibodies thereto or nucleotides encoding same. The invention additionally discloses methods of inducing an immune response to and OMP21 in an animal, preferably a human, methods of treating and methods of diagnosing infections in an animal, preferably a human, and kits therefor.

Moraxella Catarrhalis Protein, Gene Sequence And Uses Thereof

View page
US Patent:
20030235592, Dec 25, 2003
Filed:
Feb 19, 2003
Appl. No.:
10/369299
Inventors:
Kenneth Tucker - Germantown MD, US
Ulrich Tillmann - Olney MD, US
Assignee:
Antex Biologics, Inc.
International Classification:
A61K039/02
C07H021/04
C12P021/02
C12N001/21
C07K014/195
US Classification:
424/190100, 536/023700, 435/069300, 435/320100, 435/252300, 530/350000
Abstract:
The invention discloses the outer membrane protein polypeptide and polypeptides derived therefrom (collectively “OMP21”), nucleotide sequences encoding said OMP21, and antibodies that specifically bind OMP21. Also disclosed are pharmaceutical compositions including prophylactic or therapeutic compositions, which may be immunogenic compositions including vaccines, comprising OMP21, antibodies thereto or nucleotides encoding same. The invention additionally discloses methods of inducing an immune response to and OMP21 in an animal, preferably a human, methods of treating and methods of diagnosing Moraxella infections in an animal, preferably a human, and kits therefor.

Moraxella Catarrhalis Protein, Gene Sequence And Uses Thereof

View page
US Patent:
6541616, Apr 1, 2003
Filed:
Oct 1, 1998
Appl. No.:
09/164714
Inventors:
Kenneth Tucker - Germantown MD
Ulrich F. Tillmann - Olney MD
Assignee:
Antex Biologics Inc. - Gaithersburg MD
International Classification:
C12N 1511
US Classification:
536 231, 536 2332, 4353201
Abstract:
The invention discloses the outer membrane protein polypeptide and polypeptides derived therefrom (collectively âOMP21â), nucleotide sequences encoding said OMP21, and antibodies that specifically bind OMP21. Also disclosed are pharmaceutical compositions including prophylactic or therapeutic compositions, which may be immunogenic compositions including vaccines, comprising OMP21, antibodies thereto or nucleotides encoding same. The invention additionally discloses methods of inducing an immune response to and OMP21 in an animal, preferably a human, methods of treating and methods of diagnosing Moraxella infections in an animal, preferably a human, and kits therefor.
Ulrich F Tillmann from Frederick, MD, age ~69 Get Report